TMS for fibromyalgia

Written in association with: Dr Stephanie Kaye-Barrett
Published:
Edited by: Kalum Alleyne

Fibromyalgia is a condition that can cause severe musculoskeletal pain, fatigue and headaches. Although there is currently no cure, transcranial magnetic stimulation has emerged as one of the most effective ways to relieve symptoms and improve quality of life for those living with fibromyalgia.

 

A human brain

 

We spoke to one of London’s top rheumatologists Dr Stephanie Kaye-Barrett about the functionality, success rates and risks of this treatment method.

 

How does transcranial magnetic stimulation work?

Transcranial magnetic stimulation (TMS) is a non-invasive technique that uses an electromagnetic field to target a very specific area of the brain. The treatment involves a series of “pulses”, delivered at one-second intervals, which cause neurons in that area of the brain to become stimulated. Treatment is delivered over a course of sessions, which has been found to give long lasting improvements for a number of different medical conditions.

 

How can transcranial magnetic simulation help with fibromyalgia?

Recent advances in brain scanning have allowed researchers to discover that certain regions of the brain, specifically those areas thought to be responsible for processing pain, are overactive in people suffering from fibromyalgia [1]. TMS inhibits this overactivity, helping to bring back normal levels of activity in these areas of the brain. Initial research has shown this to be effective in many cases, which is an incredibly exciting development for the estimated 2% of the population thought to suffer from fibromyalgia [2].

 

How many times can you have transcranial magnetic stimulation?

Our standard treatment protocol is for 20 sessions, and studies into the use of TMS for fibromyalgia suggest that people who respond should begin to do so after around five sessions. One study [3] included a six-month follow up, and found that the improvements were sustained throughout this time. Maintenance treatments can also be given, with the aim of “topping up” the effect, which, although not yet studied for fibromyalgia, has been shown to reduce the risk of relapse in people being treated for depression [4].

 

Are there any side effects?

TMS is generally very well tolerated, with a low risk of very mild side effects for most people. The most common of these is headache, which has been reported to affect around 10% of TMS patients, although it is usually brief and responds well to painkillers. Other reported side effects are neck stiffness and mild dizziness, although these are again usually short lasting [5]. A trained specialist will monitor you throughout treatment in the unlikely event that you need to stop the session. Although a relatively novel treatment for fibromyalgia, TMS has been used for other conditions for over 25 years, with an excellent safety record.

 

How successful is transcranial magnetic stimulation for fibromyalgia?

Currently there is no cure for fibromyalgia, with treatment instead focusing on symptomatic relief. A recent change to the NICE guidelines has also meant that painkillers are no longer routinely offered to people with fibromyalgia, as these were deemed to do more harm than good in many cases [6]. This has left many sufferers with very limited resources available with which to manage their condition. In the studies that have been done so far, TMS appears to be effective at both reducing pain, and improving quality of life in people with fibromyalgia, all without long-term medication or harmful side effects [7].

 

It must be noted, however, that as with all medical interventions, there are some people who appear not to respond to treatment. However, for the majority of people that do respond, this is an incredibly exciting breakthrough that could give hope to the millions of people who are suffering from this debilitating condition.

 

For expert treatment of fibromyalgia or any other rheumatological issue like gout, osteoporosis or arthritis, visit Dr Stephanie Kaye-Barrett’s Top Doctors profile, where you can view her scheduling information and request an appointment with her.

 

References:

1. van Ettinger-Veenstra, H., Boehme, R., Ghafouri, B., Olausson, H., Wicksell, R. K., & Gerdle, B. (2020). Exploration of Functional Connectivity Changes Previously Reported in Fibromyalgia and Their Relation to Psychological Distress and Pain Measures. Journal of clinical medicine, 9(11), 3560. https://doi.org/10.3390/jcm9113560

2. Heidari, F., Afshari, M., & Moosazadeh, M. (2017). Prevalence of fibromyalgia in general population and patients, a systematic review and meta-analysis. Rheumatology international, 37(9), 1527–1539. https://doi.org/10.1007/s00296-017-3725-2

3. Tanwar, S., Mattoo, B., Kumar, U., & Bhatia, R. (2020). Repetitive transcranial magnetic stimulation of the prefrontal cortex for fibromyalgia syndrome: a randomised controlled trial with 6-months follow up. Advances in Rheumatology, 60.

4. Richieri, R., Guedj, E., Michel, P., Loundou, A., Auquier, P., Lançon, C., & Boyer, L. (2013). Maintenance transcranial magnetic stimulation reduces depression relapse: a propensity-adjusted analysis. Journal of affective disorders, 151(1), 129–135. https://doi.org/10.1016/j.jad.2013.05.062

5. Rossi, S., Antal, A., Bestmann, S., Bikson, M., Brewer, C., Brockmöller, J. & Hallett, M. (2020). Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: expert guidelines.

6. https://www.nice.org.uk/guidance/ng193/chapter/Recommendations

7. Boyer, L., Dousset, A., Roussel, P., Dossetto, N., Cammilleri, S., Piano, V., ... & Guedj, E. (2014). rTMS in fibromyalgia: a randomized trial evaluating QoL and its brain metabolic substrate. Neurology, 82(14), 1231-1238.

By Dr Stephanie Kaye-Barrett
Rheumatology

Dr Stephanie Kaye-Barrett is one of central London's leading rheumatologists, with over 20 years of consultant-grade experience. She specialises in injectable and osteoporosis treatment and the resolution of painful musculoskeletal conditions including gout, fibromyalgia syndrome (FMS), arthritis, and rheumatoid arthritis, alongside hypermobility and inflammatory joint diseases.

She is the founder of RTMS London at The London Clinic, the first rheumatology clinic in the UK to offer the repetitive transcranial magnetic stimulation (rTMS) brain stimulation technique for fibromyalgia and chronic musculoskeletal pain. RTMS is a treatment method that requires no medication and is recommended by the National Institute for Care and Health Excellence (NICE) for depression. the safety record of TMS has been well-established over many years of use. Dr Barrett introduced this to treat non-inflammatory musculoskeletal pain that has not responded to usual modalities. Studies have also found that a course of rTMS treatments has been found to reduce pain symptoms in many patients with fibromyalgia. 

Furthermore, Dr Kaye-Barrett, who also treats lateral hip pain/trochanteric bursitis, shoulder pain, tennis elbow, and plantar fascitis, leads 'one-stop' rheumatology services at her clinics, where she advises on prevention, detection, and treatment of musculoskeletal pain and fibromyalgia. Additionally, she is a specialist in new biological therapies for the treatment of rheumatoid arthritis and persistent inflammatory arthritis of the knee, in particular.

Due to her exemplary work, Dr Kaye-Barrett has been featured on BBC's series called "The Diagnosis Detectives", where leading experts in the UK diagnose patients with puzzling symptoms. 

Dr Kaye-Barrett initially qualified from Liverpool University School of Medicine, winning the final year clinical medical prize. She won the Graham White scholarship and Roaf Travelling scholarship to pursue specialist training abroad before receiving the Junior Clinical Fellowship from Arthritis Research UK. Her research subsequently led to her completing an MD at the Royal Free Hospital.

Among her many roles in public associations, Dr Kaye-Barrett was elected President of the Royal Society of Medicine, Rheumatology Division, in 2017 where she is now a trustee and member of council. She is highly involved in her field via both research, and the education of future rheumatologists. Her research focuses included osteoporosis, vitamin D deficiency, gout, and early identification of rheumatoid arthritis. Dr Kaye-Barrett lectures nationally and internationally, and she underwent training as an appraiser for the Independent Doctors Federation (IDF). Furthermore, Dr Kaye-Barrett has been featured in all published Tatler's 250 Top Doctors Guides.

Currently, Dr Kaye-Barrett is working with the Royal Society of Medicine to provide medical education in live webinars and interviews regarding COVID-19 and the Cytokine Storm, as well as other autoimmune and auto inflammatory topics in relation to COVID-19. These live interviews and webinars were broadcast to 22 countries around the globe.

View Profile

Overall assessment of their patients


  • Related procedures
  • Platelet-rich plasma
    Ozone therapy
    Neuropathic pain
    Vasculitis
    Elbow Pain
    Bursitis
    Knee osteoarthritis
    Growth factors
    Trapped nerve
    Spinal osteoarthritis
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.